GIVEN DOUGLAS B 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Jan 19, 2021
Insider Transaction Report
Form 4
GIVEN DOUGLAS B
Director
Transactions
- Sale
Common Stock
2021-01-15$83.28/sh−3,000$249,840→ 12,500 total(indirect: By Trust)
Holdings
- 119,368
Common Stock
- 15,000(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.98 to $83.40, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F2]Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.
- [F3]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
- [F4]Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.